Patent Document ID: 8822665
Application ID: 13263050
Patent Flag: 1

Claim One:
1. A product, which is: a nucleic acid coding for a polypeptide, the sequence of which consists of less than 100 amino acids, wherein the sequence of said polypeptide comprises a sequence consisting of, in N- to C-terminal orientation, the sequence of the signal peptide of the G protein of a non-apoptotic rabies virus strain, the sequence of a fragment of the ectodomain of said G protein, wherein said ectodomain fragment is a C-terminal fragment of said ectodomain consisting of one to four amino acids, and the sequence of the transmembrane domain of said G protein, wherein the sequence of said polypeptide further comprises: i. the sequence of SEQ ID NO: 6, or ii. a sequence, which: is of 34 to 54 amino acids, is at least 94% identical to said sequence of SEQ ID NO: 6 over the entire length of the shortest of the two sequences, comprises a PDZ-BS sequence, wherein said PDZ-BS sequence is QTRL (SEQ ID NO: 10), said sequence being referred to as variant sequence A, or iii. a fragment of said sequence of SEQ ID NO: 6 or of said variant sequence A, wherein said fragment is of at least 34 amino acids and has retained the PDZ-BS sequence of said sequence of SEQ ID NO: 6 or of said variant sequence A, respectively, or a vector comprising said nucleic acid, or a cell comprising said nucleic acid and/or said vector, or a pharmaceutical composition or drug, comprising at least one of said nucleic acid, vector and cell.